Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knoll

Showing results (41-50 of 4,329) with videos related to

Pageof 433
Sort By:
Journal of Neural Transmission|January 1, 1978
The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJ Knoll
Der Internist|February 12, 1998
[Vitamin D substitution in chronic renal failure]O Knoll
Voprosy Meditsinskoi Khimii|March 21, 1998
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B]J Knoll
Aesthetic Plastic Surgery|April 29, 2020
Invited Discussion on: A Prospective Study of Breast Morphological Changes and the Correlative Factors After Periareolar Dual-Plane Augmentation Mammaplasty with Anatomic ImplantBianca Knoll
Advances in Biochemical Psychopharmacology|January 1, 1982
Satietin: endogenous regulation of food intakeJ Knoll
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
(-)Deprenyl (selegiline) in Parkinson's disease: a pharmacologist's commentJ Knoll
Annual Review of Physical Chemistry|March 12, 2004
Interfaces and thin films as seen by bound electromagnetic wavesW Knoll
Neurochemical Research|July 2, 2003
Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drivesJoseph Knoll
Activitas Nervosa Superior|September 1, 1977
The effect of para-Br-methamphetamine on aggressive behaviour [proceedings]B Knoll
Pharmacology & Toxicology|August 1, 1994
Memories of my 45 years in researchJ Knoll
Pageof 433

Showing results (41-50 of 4,329) with videos related to

Sort By:
Pageof 433
Journal of Neural Transmission|January 1, 1978
The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJ Knoll
Der Internist|February 12, 1998
[Vitamin D substitution in chronic renal failure]O Knoll
Voprosy Meditsinskoi Khimii|March 21, 1998
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B]J Knoll
Aesthetic Plastic Surgery|April 29, 2020
Invited Discussion on: A Prospective Study of Breast Morphological Changes and the Correlative Factors After Periareolar Dual-Plane Augmentation Mammaplasty with Anatomic ImplantBianca Knoll
Advances in Biochemical Psychopharmacology|January 1, 1982
Satietin: endogenous regulation of food intakeJ Knoll
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
(-)Deprenyl (selegiline) in Parkinson's disease: a pharmacologist's commentJ Knoll
Annual Review of Physical Chemistry|March 12, 2004
Interfaces and thin films as seen by bound electromagnetic wavesW Knoll
Neurochemical Research|July 2, 2003
Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drivesJoseph Knoll
Activitas Nervosa Superior|September 1, 1977
The effect of para-Br-methamphetamine on aggressive behaviour [proceedings]B Knoll
Pharmacology & Toxicology|August 1, 1994
Memories of my 45 years in researchJ Knoll
Pageof 433